drugset / Trial / NCT07189936

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

NCT07189936 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Long COVID is defined by a range of symptoms affecting multiple organs that persist for more than three months following an acute SARS-CoV-2 infection. Approximately 7% of individuals who recover from SARS-Cov-2 infection develop Long COVID. Long COVID Postural Orthostatic Tachycardia Syndrome (LCPOTS) symptoms include fatigue, exercise intolerance, orthostatic intolerance, syncope, and heightened orthostatic tachycardia. Research has found that decreased parasympathetic activity in LCPOTS increases the production of highly immunogenic neoantigens Isolevuglandins (IsoLG-adducts). IsoLG-adducts induce formation of circulating monocyte/T cell complexes(doublets) leading to the persistent and unresolved immune response that continues after the initial infection. The purpose of the this research, is to study the effects of 2-hydroxybenzylamine (2-HOBA), an Iso-LG-adduct scavenger, its effects in immune markers and compare it with Placebo

Timeline

Start
2025-12-18
Primary completion
2028-06-30
Completion
2029-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator 2-(AMINOMETHYL)PHENOL Small molecule 500 mg —